ID 405422332 · FY 2022–2024 · 3 years
კომპანიის ძირითად საქმიანობას წარმოადგენს: 46460-საბითუმო ვაჭრობა ფარმაცევტული საქონლით.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2022 | 2023 | 2024 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 39.8% | 42.4% | 41.5% |
| EBITDA Margin | 7.2% | 8.4% | 32.5% |
| EBITDAR | 775 | 972 | 5,106 |
| EBITDAR Margin | 7.6% | 8.7% | 32.8% |
| EBIT Margin | 7.1% | 8.2% | 32.4% |
| Net Profit Margin | 11.6% | 13.7% | 33.2% |
| Operating Expense % of Sales | 32.6% | 34.0% | 9.0% |
| Returns | |||
| Return on Assets (ROA) | 23.1% | 148.5% | 97.1% |
| Return on Equity (ROE) | 26.1% | 272.3% | 151.4% |
| ROIC [EBIT / Invested Capital] | 377.4% | 237.4% | 270.6% |
| Leverage & liquidity | |||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 88.6% | 54.5% | 64.2% |
| Net Debt | -4,311 | -174 | -1,557 |
| Cash & Equivalents | 4,311 | 174 | 1,557 |
| Total Debt | N/A | N/A | N/A |
| Efficiency & working capital | |||
| Inventory Turnover | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A |
| Receivables Turnover | 18.44x | 20.58x | 4.71x |
| Days Sales Outstanding (DSO) | 19.8 | 17.7 | 77.5 |
| Payables Turnover | 10.57x | 13.75x | 4.77x |
| Days Payable Outstanding (DPO) | 34.5 | 26.6 | 76.5 |
| Cash Conversion Cycle | -14.7 days | -8.8 days | 1.0 days |
| Asset Turnover | 2.00x | 10.83x | 2.92x |
| Cash flow & dividends | |||
| Operating Cash Flow | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).